Cefixime for the treatment of syphilis.
Phase 3
- Registration Number
- PER-004-23
- Lead Sponsor
- IVERSITY OF SOUTHERN CALIFORNIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Without startig enrollment
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
- Diagnosed cases of early syphilis with RPR titer =1:8 within 3 weeks prior to enrollment.
- 16 years of age or older.
- Individuals with HIV infection must be virologically suppressed or have a CD4 count = 350 cells/mm3.
Exclusion Criteria
- Pregnancy or a positive pregnancy test on the day of enrollment.
- Patients showing signs and symptoms of neurosyphilis.
- Concomitant antimicrobial therapy with activity against syphilis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RPR<br> NAME OF THE RESULT: Cure rate<br> PERIOD OF TIME WHERE TE MEASUREMENT WILL BE CONDUCTED AND WHICH WILL ALLOW OBTAINING THE<br> PRIMARY RESULT: 24 weeks
- Secondary Outcome Measures
Name Time Method RPR<br> NAME OF THE RESULT: Cure rate<br> PERIOD OF TIME WHERE TE MEASUREMENT WILL BE CONDUCTED AND WHICH WILL ALLOW OBTAINING THE<br> PRIMARY RESULT: 24 weeks ;NA<br> NAME OF THE RESULT: NA<br> PERIOD OF TIME WHERE TE MEASUREMENT WILL BE CONDUCTED AND WHICH WILL ALLOW OBTAINING THE<br> PRIMARY RESULT: NA